General Information of Drug (ID: DMIZ9ON)

Drug Name
BRD1240 Drug Info
Synonyms
BRD-1240; 3-(1,3-benzodioxol-5-yl)-1-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea; CHEMBL2355724; CHEBI:96315; BRD-K63431240-001-01-4; BRD-K63431240-001-02-2; Q27168409
Cross-matching ID
PubChem CID
54618771
ChEBI ID
CHEMBL96315
TTD Drug ID
DY9CM8

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Steroid biosynthesis 2.38 0.00e+0 19/20 (95%) MSMO1;SQLE;DHCR7;...
Terpenoid backbone biosynthesis 2.22 0.00e+0 18/22 (81.82%) HMGCS1;IDI1;HMGCR;...
Vibrio cholerae infection 2.10 0.00e+0 44/50 (88%) ATP6V1D;SLC12A2;PRKACB;...
Chemokine signaling pathway 2.06 0.00e+0 163/192 (84.9%) GNG11;CCL20;CXCL13;...
Sphingolipid metabolism 2.02 0.00e+0 32/49 (65.31%) PLPP3;GALC;DEGS1;...
B cell receptor signaling pathway 1.99 0.00e+0 71/81 (87.65%) PIK3R1;CD79A;AKT3;...
Viral protein interaction with cytokine and cytokine re... 1.92 0.00e+0 84/100 (84%) CCL20;CXCL13;CXCL14;...
SNARE interactions in vesicular transport 1.92 0.00e+0 19/33 (57.58%) STX1A;STX3;STX7;...
Epithelial cell signaling in Helicobacter pylori infect... 1.91 0.00e+0 62/70 (88.57%) ATP6V1D;CXCL1;HBEGF;...
Rheumatoid arthritis 1.89 0.00e+0 78/93 (83.87%) ATP6V1D;CCL20;CXCL1;...
Autophagy 1.89 0.00e+0 113/169 (66.86%) DDIT4;PRKACB;PIK3R1;...
Vasopressin-regulated water reabsorption 1.87 2.02e-3 40/44 (90.91%) AQP3;PRKACB;CREB1;...
Osteoclast differentiation 1.87 1.87e-3 117/127 (92.13%) PPARG;IRF9;IFNGR1;...
TNF signaling pathway 1.86 3.47e-3 103/112 (91.96%) CCL20;TNFAIP3;CXCL1;...
Butanoate metabolism 1.82 5.66e-3 23/28 (82.14%) HMGCS1;ACAT1;ACAT2;...
Synthesis and degradation of ketone bodies 1.80 1.14e-2 9/10 (90%) HMGCS1;ACAT1;ACAT2
Kaposi sarcoma-associated herpesvirus infection 1.78 1.36e-2 172/193 (89.12%) GNG11;IRF9;CXCL1;...
PD-L1 expression and PD-1 checkpoint pathway in cancer 1.77 1.48e-2 79/89 (88.76%) IFNGR1;EML4;PIK3R1;...
FoxO signaling pathway 1.76 1.47e-2 118/131 (90.08%) IL7R;PRKAG2;CCNG2;...
Alcoholism 1.76 1.40e-2 86/186 (46.24%) GNG11;PRKACB;CALML5;...
Relaxin signaling pathway 1.75 1.44e-2 114/129 (88.37%) GNG11;PRKACB;MMP1;...
Apelin signaling pathway 1.74 1.65e-2 117/137 (85.4%) GNG11;CCN2;PRKAG2;...
mTOR signaling pathway 1.74 1.58e-2 114/154 (74.03%) DDIT4;ATP6V1D;RPS6KA2;...
Hepatitis C 1.71 1.92e-2 139/157 (88.54%) IRF9;IFIT1;LDLR;...
Longevity regulating pathway 1.71 1.89e-2 90/151 (59.6%) PPARG;PRKAG2;PRKACB;...
PPAR signaling pathway 1.69 2.33e-2 66/74 (89.19%) HMGCS1;SCD;FABP4;...
Measles 1.68 2.47e-2 133/139 (95.68%) TNFAIP3;IRF9;IRF7;...
VEGF signaling pathway 1.68 2.38e-2 50/59 (84.75%) PIK3R1;MAPKAPK3;AKT3;...
Lipid and atherosclerosis 1.66 2.86e-2 190/215 (88.37%) PPARG;CD36;CXCL1;...
Arginine and proline metabolism 1.65 2.82e-2 39/50 (78%) ALDH2;OAT;GOT1;...
Ribosome biogenesis in eukaryotes -1.76 3.63e-2 52/108 (48.15%) RPP38;NOP10;POP4;...
Systemic lupus erythematosus -1.97 5.24e-3 45/135 (33.33%) C8A;FCGR2A;TNF;...
Spliceosome -2.13 0.00e+0 101/150 (67.33%) HNRNPA3;DDX42;TCERG1;...
RNA transport -2.14 0.00e+0 128/186 (68.82%) EIF3F;AAAS;EIF4A3;...
Retinol metabolism -2.53 0.00e+0 41/68 (60.29%) RPE65;UGT2B4;ADH6;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Osteosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
U-2 OS CVCL_0042 Homo sapiens 10uM 6H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
VCaP CVCL_2235 Homo sapiens 4uM 6H, 24H